Clinical Trials Logo

Filter by:
  • Active, not recruiting  
  • Page [1] ·  Next »
NCT ID: NCT06449170 Active, not recruiting - Diet, Healthy Clinical Trials

Discovery of Biomarkers of Intake of of Highly Consumed Foods in Mexico

BIAMEX
Start date: January 1, 2023
Phase: N/A
Study type: Interventional

To determine diet-health associations, researchers rely on information obtained from dietary instruments, such as the 24-hour recall (R24H), food frequency questionnaires (FFQ) and food diaries, in clinical studies. However, it is widely recognized that the information provided by the different instruments is biased by different factors including recall errors and respondent burden. The impact of the variability produced by this bias decreases the robustness of diet-health associations which results in the creation of less efficient standards and recommendations for our population. To address this, the discovery of biomarkers of food intake (BFIs) is an objective tool that indicates exposure to specific foods or various dietary patterns. BFIs allow the calibration of dietary information to obtain the real consumption of the individual and thus clarify the relationship between different pathologies of interest and the intake of different foods. BIAMEX will initially focus on the discovery of BFIs of nopal, corn tortilla, mango, avocado, guava and amaranth. For this purpose, a controlled crossover intervention study is being carried out with the 6 foods to be investigated where 24h urine and plasma samples are being collected. Subsequently, the samples collected will be analyzed by mass spectrometry.

NCT ID: NCT06400914 Active, not recruiting - Ametropia Clinical Trials

Clinical Evaluation of Biomedics Monthly Sphere and Avaira Vitality Sphere

Start date: April 2, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to compare the short-term clinical performance of two sphere contact lenses.

NCT ID: NCT06269848 Active, not recruiting - Body Composition Clinical Trials

Identification of Sports Talents in Boxers

Start date: February 29, 2024
Phase:
Study type: Observational

This study aims to identify sporting talents by profiling a group of young boxers residing in the State of Mexico using unsupervised machine learning methods. This study is supported by Asociación de Boxeo del Estado de México AC (ABEM) and powered by DBSS.

NCT ID: NCT06160583 Active, not recruiting - Anesthesia Clinical Trials

General Anesthesia for Cesarean Section, Maternal and Perinatal Outcomes

Start date: November 12, 2023
Phase:
Study type: Observational [Patient Registry]

To evaluate the maternal and perinatal outcomes that occur in obstetric patients undergoing cesarean section surgery under general anesthesia at the Fray Antonio Alcalde Civil Hospital of Guadalajara.

NCT ID: NCT06080139 Active, not recruiting - Refugee Health Clinical Trials

Supporting Refugee Parenting Community and Family Mental Health in Tijuana

Start date: February 6, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to better understand and support parenting practices and family mental health among migrant parents in Tijuana, Mexico. the main questions it aims to answer are: 1. What parenting skills are most needed for learning? 2. How can we teach them in a participatory way respecting cultural values and norms? 3. How does this parenting program affect parental and child interactions and mental health? Participants will 1. have the opportunity to give their opinions on the priority parenting skills needed and on which curriculum to use for learning these skills; 2. participate in small group learning sessions twice a week for 4 weeks; 3. be asked to complete a few surveys before and after the learning sessions, and 2 months after they complete the learning sessions. Researchers will compare parents randomly assigned to parenting sessions group with waitlist control group (starting learning sessions 1 month later) to see if the group learning benefits parent-child interactions, parental stress, and parental confidence in parenting.

NCT ID: NCT06039579 Active, not recruiting - HIV Infections Clinical Trials

Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

CINNAMON
Start date: October 25, 2023
Phase: Phase 2
Study type: Interventional

The primary purpose of the study is to evaluate the antiviral activity of orally administered VH4004280 and VH4011499 monotherapy over 10 days in human immunodeficiency virus (HIV-1) infected Treatment-Naïve (TN) participants.

NCT ID: NCT05971940 Active, not recruiting - Type 2 Diabetes Clinical Trials

A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

ACHIEVE-1
Start date: August 9, 2023
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to determine safety and efficacy of orforglipron compared with placebo in adult participants with type 2 diabetes and inadequate glycemic control with diet and exercise alone. The study will last approximately 54 weeks.

NCT ID: NCT05966376 Active, not recruiting - Clinical trials for Coronary Intervention

Efficacy and Safety of Hemostatic Methods in Distal Radial Artery Approach for Cardiac Catheterization

HEMOSTAD-INC
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Comparison of PreludeSYNC distal and Modified Terumo Radial Band in patients with distal radial approach.

NCT ID: NCT05960227 Active, not recruiting - Acute Kidney Injury Clinical Trials

Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury

Start date: January 6, 2023
Phase: Phase 2
Study type: Interventional

This clinical trial aims to carry out research on the effect on hemoglobin and renal function of intravenous administration of iron dextran as a repletion strategy in patients with iron deficiency anemia and acute kidney injury, in which the patient may benefit from this drug as it is expected to correct anemia, ferropenia and renal function parameters, when compared with a control group (placebo), the safety of the drug will also be assessed by recording adverse effects. The investigators will point out with the patient the risks and benefits of their inclusion in this type of study and the investigators will attend to all the doubts that are generated, as well as immediately report to the research ethics committee any serious adverse effects. The results will be presented at national and international conferences and will be published in high-impact journals, and will also be the subject of a thesis to achieve the title of specialist.

NCT ID: NCT05952856 Active, not recruiting - Clinical trials for Hypercholesterolemia

A Study of MK-0616 (Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

Start date: August 10, 2023
Phase: Phase 3
Study type: Interventional

The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The primary hypothesis is that MK-0616 is superior to placebo on mean percent change from baseline in low-density lipoprotein cholesterol (LDL-C) at Week 24.